Armodafinil Patent Expiration
Armodafinil is Used for promoting wakefulness in patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. It was first introduced by Cephalon Inc
Armodafinil Patents
Given below is the list of patents protecting Armodafinil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nuvigil | US7132570 | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
Dec 18, 2023
(Expired) | Cephalon |
| Nuvigil |
US7132570 (Pediatric) | Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil |
Jun 18, 2024
(Expired) | Cephalon |
| Nuvigil | US7297346 | Pharmaceutical formulations of modafinil |
Nov 29, 2023
(Expired) | Cephalon |
| Nuvigil |
US7297346 (Pediatric) | Pharmaceutical formulations of modafinil |
May 29, 2024
(Expired) | Cephalon |
| Nuvigil | USRE37516 | Acetamide derivative having defined particle size |
Oct 06, 2014
(Expired) | Cephalon |
| Nuvigil |
USRE37516 (Pediatric) | Acetamide derivative having defined particle size |
Apr 06, 2015
(Expired) | Cephalon |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Armodafinil Generics
Several generic applications have been filed for Armodafinil. The first generic version for Armodafinil was by Mylan Pharmaceuticals Inc and was approved on Jun 1, 2012. And the latest generic version is by Mylan Pharmaceuticals Inc and was approved on May 9, 2019.
Given below is the list of companies who have filed for Armodafinil generic.
1. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 5 different strengths of generic version for Armodafinil. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet | Prescription | ORAL | AB | Jun 1, 2012 |
| 150MG | tablet | Prescription | ORAL | AB | Jun 1, 2012 |
| 250MG | tablet | Prescription | ORAL | AB | Jun 1, 2012 |
| 200MG | tablet | Prescription | ORAL | AB | May 9, 2019 |
| 100MG | tablet | Prescription | ORAL | AB | May 9, 2019 |
2. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Armodafinil. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
| 50MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
| 150MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
| 250MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Armodafinil. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 150MG | tablet | Prescription | ORAL | AB | Mar 6, 2018 |
| 250MG | tablet | Prescription | ORAL | AB | Mar 6, 2018 |
| 50MG | tablet | Prescription | ORAL | AB | Mar 6, 2018 |
| 200MG | tablet | Prescription | ORAL | AB | Dec 7, 2018 |
4. COREPHARMA
Corepharma Llc has filed for 3 different strengths of generic version for Armodafinil. Given below are the details of the strengths of this generic introduced by Corepharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 150MG | tablet | Discontinued | ORAL | N/A | Mar 25, 2019 |
| 250MG | tablet | Discontinued | ORAL | N/A | Mar 25, 2019 |
| 50MG | tablet | Discontinued | ORAL | N/A | Mar 25, 2019 |
5. NATCO PHARMA LTD
Natco Pharma Ltd has filed for 5 different strengths of generic version for Armodafinil. Given below are the details of the strengths of this generic introduced by Natco Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
| 150MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
| 250MG | tablet | Prescription | ORAL | AB | Nov 28, 2016 |
| 100MG | tablet | Prescription | ORAL | AB | Sep 28, 2017 |
| 200MG | tablet | Prescription | ORAL | AB | Sep 28, 2017 |
6. WATSON LABS INC
Watson Laboratories Inc has filed for 2 different strengths of generic version for Armodafinil. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG | tablet | Discontinued | ORAL | N/A | Aug 29, 2012 |
| 100MG | tablet | Discontinued | ORAL | N/A | Aug 29, 2012 |